Home › Stocks › ICPT › All Fund Holders
ICPT — INTERCEPT PHARMACEUTICALS IN · All Fund Holders
Funds holding (latest): 35 · Reported value held: $222.04M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| UBS Group AG history | Q3 2023 | 3.01M | $55.81M | 0.02% | Add |
| Vanguard Group history | Q3 2023 | 2.07M | $38.40M | 0.00% | Reduce |
| Goldman Sachs Group history | Q3 2023 | 1.02M | $18.89M | 0.00% | Add |
| Geode Capital Management history | Q3 2023 | 793.32K | $14.71M | 0.00% | Add |
| D. E. Shaw & Co history | Q3 2023 | 791.34K | $14.67M | 0.02% | Add |
| Balyasny Asset Management history | Q3 2023 | 702.90K | $13.03M | 0.03% | New |
| Morgan Stanley history | Q3 2023 | 576.77K | $10.69M | 0.00% | Add |
| Bank of America Corp history | Q3 2023 | 402.36K | $7.46M | 0.00% | Add |
| Northern Trust Corp history | Q3 2023 | 383.32K | $7.11M | 0.00% | Add |
| Citadel Advisors history | Q3 2023 | 338.37K | $6.27M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q3 2023 | 289.77K | $5.37M | 0.00% | Add |
| BNY Mellon history | Q3 2023 | 252.35K | $4.68M | 0.00% | Add |
| Millennium Management history | Q3 2023 | 229.33K | $4.25M | 0.00% | Reduce |
| Prudential Financial history | Q1 2023 | 225.38K | $3.03M | 0.01% | New |
| Citigroup Inc history | Q3 2023 | 143.41K | $2.66M | 0.00% | Reduce |
| Point72 Asset Management history | Q4 2022 | 166.30K | $2.06M | 0.01% | Reduce |
| Charles Schwab Investment Management history | Q3 2023 | 109.72K | $2.03M | 0.00% | Reduce |
| MFS Investment Management history | Q3 2023 | 95.55K | $1.77M | 0.00% | Add |
| Two Sigma Investments history | Q3 2023 | 84.72K | $1.57M | 0.00% | Add |
| Wells Fargo & Co history | Q3 2023 | 72.41K | $1.34M | 0.00% | Reduce |
| Invesco Ltd history | Q3 2023 | 69.47K | $1.29M | 0.00% | Add |
| Wellington Management Group history | Q1 2023 | 81.97K | $1.10M | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q3 2023 | 48.74K | $903.66K | 0.00% | Add |
| Principal Global Investors history | Q3 2023 | 39.83K | $738.49K | 0.00% | Add |
| Legal & General Investment Management America history | Q3 2023 | 30.74K | $569.90K | 0.00% | Add |
| Marshall Wace history | Q3 2023 | 22.50K | $417.15K | 0.00% | Add |
| Franklin Resources history | Q3 2023 | 18.63K | $345.33K | 0.00% | Add |
| Manulife Financial history | Q3 2023 | 14.98K | $277.82K | 0.00% | Add |
| Deutsche Bank AG history | Q3 2023 | 14.76K | $273.56K | 0.00% | Reduce |
| Janus Henderson Group history | Q3 2023 | 13.70K | $253.81K | 0.00% | Hold |
| Maverick Capital history | Q3 2021 | 2.83K | $42.00K | 0.00% | New |
| Renaissance Technologies history | Q3 2023 | 825.80K | $15.31K | 0.03% | Reduce |
| Baillie Gifford & Co history | Q1 2023 | 101 | $1.36K | 0.00% | Hold |
| Lazard Asset Management history | Q1 2023 | 41.04K | $551 | 0.00% | Hold |
| T. Rowe Price Associates history | Q3 2023 | 26.39K | $490 | 0.00% | Add |